The short answer
Potassium supplements or potassium-containing salt substitutes can cause a significant rise in blood potassium with lisinopril. Use should be clinician-directed with frequent potassium monitoring, including when treating a documented deficiency.
What this answer covers
Applies to systemic lisinopril with concentrated potassium products; ordinary food intake is not automatically equivalent.
- Supplement or preparation
- Potassium
- Medication ingredient
- lisinopril
Evidence and practical considerations
Side effects & toxicity
Exact FDA labeling and an exact-lisinopril cohort establish a clinically important hyperkalemia risk from concurrent potassium products.
- Exact scope
- potassium supplements and potassium-containing salt substitutes with lisinopril
- Medication form and route
- systemic lisinopril exposure
- Timing or duration
- Risk is present during concurrent use and is greatest after initiation, dose increases, renal-function decline, dehydration, or addition of another potassium-raising agent.
What remains uncertain
- A clinician may intentionally prescribe potassium for documented hypokalemia, but the label requires caution and frequent monitoring.
- Ordinary food intake is not equated with concentrated supplements or potassium-chloride salt substitutes.
Factors that may matter: renal impairment; diabetes mellitus; heart failure; older age; higher lisinopril dose; potassium-sparing diuretic use; high baseline potassium.
Read the supporting source summaries
Source 1: FDA prescribing information
dailymed.nlm.nih.gov · Source check Jul 25, 2026
Population: Patients receiving lisinopril.
The label states that potassium supplements or potassium-containing salt substitutes may produce significant serum-potassium increases and require caution and frequent monitoring.
The label does not quantify risk for each supplement dose or salt-substitute formulation.
Source 2: peer-reviewed clinical prediction cohort
pmc.ncbi.nlm.nih.gov · Source check Jul 25, 2026
Population: 5,171 patients with possible chronic kidney disease starting lisinopril.
Potassium-supplement use was among the predictors of hyperkalemia; observed risk ranged from 0.7% in the lowest to 6.9% in the highest predicted-risk quintile.
Observational cohort and prediction model; supplement dose and causal effect were not randomized.
Research assessment: · Open full citations ↗
Timing & monitoring
Exact labeling explicitly supplies the avoid-unless-indicated and frequent-monitoring rule.
- Exact scope
- potassium supplements and potassium-containing salt substitutes with lisinopril
- Medication form and route
- systemic lisinopril exposure
- Timing or duration
- Applies throughout concurrent use; monitoring should intensify after initiation, dose changes, renal-function changes, or addition of a potassium-raising product.
What remains uncertain
- This is not an absolute ban when a clinician is treating demonstrated hypokalemia.
- Potassium-rich ordinary foods and concentrated supplements are not automatically equivalent; the patient-specific dietary plan controls.
Factors that may matter: renal impairment; diabetes mellitus; heart failure; high baseline potassium; potassium-sparing diuretics.
Read the supporting source summaries
Source 1: FDA prescribing information
dailymed.nlm.nih.gov · Source check Jul 25, 2026
Population: Patients receiving lisinopril.
The label says use cautiously, if at all, and with frequent serum-potassium monitoring; if needed for demonstrated hypokalemia, use only with caution and monitoring.
No universal laboratory interval is specified.
Source 2: United States government patient drug information
medlineplus.gov · Source check Jul 25, 2026
Population: Patients prescribed lisinopril.
Patients are told to discuss potassium supplements and salt substitutes with the prescriber before use.
Consumer guidance does not replace individualized monitoring orders.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Research summary published |
Article revision: 2f946310c1a47f4a
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.